ARCHIVES

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980

Bill Promotes Awareness Of Pediatric Cancer Research.

September 22, 2000

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

Journal Editors Were Unaware Of Tobacco Funding.

March 28, 2008

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992